Stay updated on Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial page.

Latest updates to the Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA revision note for v3.4.2 was added and the previous revision note v3.4.1 was removed.SummaryDifference0.0%

- Check43 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1; no changes to the study details or visible content.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision history updated from v3.3.3 to v3.3.4; no substantive changes to the study details or eligibility criteria are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check87 days agoChange DetectedAdded a consolidated Locations section listing participating sites across Alabama, California, Colorado, Florida, Indiana, Kansas, Minnesota, New Jersey, North Carolina, Texas, Adjara, and Imereti. This replaces the prior separate location blocks and centralizes site information for potential participants.SummaryDifference1%

Stay in the know with updates to Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial page.